Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment |
Advanced Malignancies and Hepatic Impairment | Phase1 | France Italy Spain United Kingdom View all |
NCT07422610 |
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer |
Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase1 | Australia Japan United States |
NCT07570979 |
Remibrutinib Open Label Roll-over Post-trial Access Protocol |
Indication of the Parent Protocol | Phase3 | Bulgaria Canada Czechia France Poland South Korea Spain Vietnam View all |
NCT07456891 |
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy |
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) | Phase3 | Australia China France Germany Italy Japan Netherlands South Korea Spain United States View all |
NCT07498426 |
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) |
Primary Immune Thrombocytopenia (ITP), Primary Evans Syndrome (ES) | Phase2 | United States | NCT07421167 |
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies |
Heterozygous or Homozygous Familial Hypercholesterolemia | Phase3 | Taiwan | NCT05682378 |
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP |
Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive | Phase2 | Australia Brazil Canada China France Germany Italy Japan Netherlands Poland South Korea Spain United States View all |
NCT07354074 |
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population |
Hidradenitis Suppurativa | Italy | NCT07543419 | |
REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria |
Paroxysmal Nocturnal Hemoglobinuria (PNH) | Italy | NCT07229235 | |
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) |
Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) | Phase3 | Argentina Australia China India Italy Japan Malaysia South Korea Switzerland Taiwan Turkey (Türkiye) United States View all |
NCT07357727 |